DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Jeff Collins will participate in the US-India BioPharma Summit (theme: “Delivering Affordable Innovation through Cross-Border Partnerships”) in Cambridge, MA
News | 06. 13. 2008
